✦ LIBER ✦

Dose escalation with overdose control using a quasi-continuous toxicity score in cancer Phase I clinical trials

✍ Scribed by Zhengjia Chen; Mourad Tighiouart; Jeanne Kowalski

Book ID: 118428073
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 278 KB
Volume: 33
Category: Article
ISSN: 1551-7144
DOI: 10.1016/j.cct.2012.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer phase I clinical trials: efficien

Cancer phase I clinical trials: efficient dose escalation with overdose control

✍ James Babb; André Rogatko; Shelemyahu Zacks 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

We describe an adaptive dose escalation scheme for use in cancer phase I clinical trials. The method is fully adaptive, makes use of all the information available at the time of each dose assignment, and directly addresses the ethical need to control the probability of overdosing. It is designed to

A novel toxicity scoring system treating

A novel toxicity scoring system treating toxicity response as a quasi-continuous variable in Phase I clinical trials

✍ Zhengjia Chen; Mark D. Krailo; Stanley P. Azen; Mourad Tighiouart 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 306 KB

A phase I dose-escalation clinical trial

A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer

✍ Nakao, A; Kasuya, H; Sahin, T T; Nomura, N; Kanzaki, A; Misawa, M; Shirota, T; Y 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 732 KB